Correction: Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma

Oncotarget. 2018 Dec 4;9(95):36817. doi: 10.18632/oncotarget.26447.

Davide Valentini¹, Martin Rao², Qingda Meng², Anna von Landenberg², Jiri Bartek Jr^{3

4}, Georges Sinclair⁴, Georgia Paraschoudi², Elke Jäger⁵, Inti Harvey-Peredo⁴, Ernest Dodoo⁴, Markus Maeurer^{1

2

5}

¹ Centre for Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital Huddinge, Stockholm, Sweden.
² Therapeutic Immunology Unit (TIM), Department of Laboratory Medicine (LABMED), Karolinska Institutet, Stockholm, Sweden.
³ Department of Neurosurgery, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
⁴ Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden.
⁵ Krankenhaus Nordwest, Division of Oncology and Hematology, Frankfurt, Germany.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.24955.].